Geode Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.5M | Buy |
2,464,779
+1,282,042
| +108% | +$1.82M | ﹤0.01% | 2910 |
|
|
2025
Q1 | $1.81M | Buy |
1,182,737
+393,140
| +50% | +$602K | ﹤0.01% | 3076 |
|
|
2024
Q4 | $1.96M | Sell |
789,597
-56,849
| -7% | -$141K | ﹤0.01% | 3134 |
|
|
2024
Q3 | $974K | Buy |
846,446
+72,309
| +9% | +$83.2K | ﹤0.01% | 3363 |
|
|
2024
Q2 | $852K | Sell |
774,137
-790,917
| -51% | -$870K | ﹤0.01% | 3372 |
|
|
2024
Q1 | $1.94M | Buy |
1,565,054
+171,506
| +12% | +$213K | ﹤0.01% | 3122 |
|
|
2023
Q4 | $1.46M | Buy |
1,393,548
+56,466
| +4% | +$59.3K | ﹤0.01% | 3204 |
|
|
2023
Q3 | $9.16M | Buy |
1,337,082
+99,673
| +8% | +$683K | ﹤0.01% | 2322 |
|
|
2023
Q2 | $12.8M | Buy |
1,237,409
+122,837
| +11% | +$1.27M | ﹤0.01% | 2140 |
|
|
2023
Q1 | $9.02M | Buy |
1,114,572
+55,824
| +5% | +$452K | ﹤0.01% | 2316 |
|
|
2022
Q4 | $16.7M | Buy |
1,058,748
+30,025
| +3% | +$473K | ﹤0.01% | 1897 |
|
|
2022
Q3 | $16.2M | Buy |
1,028,723
+71,507
| +7% | +$1.13M | ﹤0.01% | 1895 |
|
|
2022
Q2 | $13.4M | Buy |
957,216
+110,825
| +13% | +$1.55M | ﹤0.01% | 2044 |
|
|
2022
Q1 | $14.6M | Buy |
846,391
+37,929
| +5% | +$654K | ﹤0.01% | 2097 |
|
|
2021
Q4 | $11.8M | Buy |
808,462
+12,636
| +2% | +$184K | ﹤0.01% | 2340 |
|
|
2021
Q3 | $14.3M | Buy |
795,826
+77,069
| +11% | +$1.39M | ﹤0.01% | 2192 |
|
|
2021
Q2 | $12.6M | Buy |
718,757
+341,893
| +91% | +$6M | ﹤0.01% | 2295 |
|
|
2021
Q1 | $9.5M | Buy |
376,864
+51,888
| +16% | +$1.31M | ﹤0.01% | 2398 |
|
|
2020
Q4 | $2.1M | Sell |
324,976
-77,096
| -19% | -$499K | ﹤0.01% | 3055 |
|
|
2020
Q3 | $1.03M | Sell |
402,072
-10,503
| -3% | -$27K | ﹤0.01% | 3198 |
|
|
2020
Q2 | $668K | Sell |
412,575
-174,519
| -30% | -$283K | ﹤0.01% | 3273 |
|
|
2020
Q1 | $610K | Buy |
587,094
+5,911
| +1% | +$6.14K | ﹤0.01% | 3213 |
|
|
2019
Q4 | $1.1M | Buy |
581,183
+90,067
| +18% | +$170K | ﹤0.01% | 3249 |
|
|
2019
Q3 | $530K | Buy |
491,116
+5,031
| +1% | +$5.43K | ﹤0.01% | 3454 |
|
|
2019
Q2 | $1.06M | Buy |
486,085
+18,992
| +4% | +$41.6K | ﹤0.01% | 3223 |
|
|
2019
Q1 | $2.8M | Buy |
467,093
+87,086
| +23% | +$521K | ﹤0.01% | 2647 |
|
|
2018
Q4 | $2.81M | Buy |
380,007
+105,361
| +38% | +$779K | ﹤0.01% | 2568 |
|
|
2018
Q3 | $3.99M | Buy |
274,646
+7,993
| +3% | +$116K | ﹤0.01% | 2502 |
|
|
2018
Q2 | $5.33M | Buy |
266,653
+21,783
| +9% | +$435K | ﹤0.01% | 2286 |
|
|
2018
Q1 | $4.29M | Buy |
244,870
+19,197
| +9% | +$336K | ﹤0.01% | 2333 |
|
|
2017
Q4 | $5.57M | Buy |
225,673
+13,664
| +6% | +$337K | ﹤0.01% | 2150 |
|
|
2017
Q3 | $5.47M | Buy |
212,009
+68,312
| +48% | +$1.76M | ﹤0.01% | 2146 |
|
|
2017
Q2 | $3.9M | Buy |
143,697
+25,661
| +22% | +$696K | ﹤0.01% | 2314 |
|
|
2017
Q1 | $3.52M | Buy |
118,036
+14,126
| +14% | +$421K | ﹤0.01% | 2324 |
|
|
2016
Q4 | $2.82M | Buy |
103,910
+52,765
| +103% | +$1.43M | ﹤0.01% | 2429 |
|
|
2016
Q3 | $1.31M | Buy |
51,145
+2,120
| +4% | +$54.3K | ﹤0.01% | 2802 |
|
|
2016
Q2 | $905K | Buy |
49,025
+5,779
| +13% | +$107K | ﹤0.01% | 2951 |
|
|
2016
Q1 | $819 | Buy |
43,246
+6,679
| +18% | +$126 | ﹤0.01% | 2990 |
|
|
2015
Q4 | $985K | Buy |
+36,567
| New | +$985K | ﹤0.01% | 2922 |
|